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MeCP2 is labeled with biotin using Cre-loxP-based recombination. To understand the molecular impact of RTT-associated mutations on cell-type-specific gene expression in vivo, we also developed an allelic series of knock-in mice bearing one of two frequent missense mutations in RTT, T158M and R106W. When combined with fluorescenceactivated cell sorting (FACS), this strategy allows the isolation of neuronal nuclei from targeted cell types, effectively circumventing cellular heterogeneity in the mouse brain and X-linked mosaicism in female mice. Our findings support a contextualized model by which both cell-and non-cell-autonomous transcriptional changes in different cell types contribute to the molecular severity of neuronal deficits in RTT, providing new directions for therapeutic development.
RESULTS
A system to genetically biotinylate MeCP2 in vivo Biotin-mediated affinity tagging has been widely used in cell and animal models for multiple experimental approaches because of the strong (K d = 4 × 10 −14 M) and specific interaction between biotin and avidin protein 29 . We exploited this approach to investigate MeCP2 function by using homologous recombination to insert a short (23-aa) affinity tag immediately upstream of the Mecp2 stop codon ( Fig. 1a and Supplementary Fig. 1a ). This tag, termed Tavi, comprises a TEV protease cleavage site and a 15-aa biotinylation consensus motif that can be post-translationally labeled with biotin by Escherichia coli biotin ligase BirA. To biotinylate the tag in cell types of interest, we also generated transgenic mice with a Cre-responsive BirA allele (herein R26 cBirA mice) ( Supplementary Fig. 1b) . Upon crossing these mice to mice expressing cell-type-specific Cre recombinase, BirA is expressed and subsequently biotinylates Tavi-tagged MeCP2 (Mecp2 Tavi ) ( Fig. 1b) . We used the EIIa-Cre mouse line 30 to generate mice ubiquitously expressing BirA (R26 BirA ) and confirmed that MeCP2 is specifically biotinylated in vivo only when BirA is expressed and the Tavi tag is present ( Fig. 1c and Supplementary Fig. 1c) .
To examine the possibility that tagging MeCP2 adversely affects its function, we assessed MeCP2 expression, DNA binding and protein-protein interactions in 20-week-old Mecp2 Tavi/y (herein TAVI) and littermate Mecp2 +/y (WT) male mice. We found that total MeCP2 protein, but not RNA, was reduced by ~40% in the brains of TAVI mice, and a similar trend toward ~40% reduction was also observed among soluble and chromatin-bound MeCP2 protein using subnuclear fractions from whole brain ( Supplementary Fig. 1d-f ). However, Tavi-tagged and untagged MeCP2 exhibited comparable levels of chromatin binding at high-and low-affinity genomic sites, including highly methylated major satellite repeats and intra-cisternal A-type particle (IAP) elements, and MeCP2-Tavi remained associated with the NCoR-SMRT co-repressor ( Supplementary Fig. 1g,h) . Although a 50% reduction in MeCP2 expression is sufficient to cause hypoactivity and subtle behavioral phenotypes in mice 31 , TAVI mice appeared similar to WT mice and did not display overt RTT-like features, as assessed by phenotypic scoring 32 , over an observational period of 20 weeks ( Fig. 1g-j, Supplementary Fig. 1i and data not shown (B.S.J.)).
RTT-like phenotypes in mice with MeCP2 missense mutations
To examine the molecular relationship between MeCP2 affinity for methylated DNA and phenotypic severity, we generated independent Mecp2 T158M-Tavi and Mecp2 R106W-Tavi knock-in mice (here T158M and R106W mice, respectively) in parallel with TAVI mice (controls) (Fig. 1a) . Relative to TAVI controls, 6-week-old T158M and R106W mice showed a ~70-80% reduction in whole-brain MeCP2 expression despite showing comparable levels of mRNA ( Fig. 1e and Supplementary Fig. 1j ), similarly to other mouse models bearing MeCP2 MBD mutations 16, 17, 20 . However, there was a trend toward higher MeCP2 protein levels in T158M than in R106W mice across development (Supplementary Fig. 2a ). Immunofluorescence (IF) staining of hippocampal sections from T158M and R106W mice revealed diffuse distribution of MeCP2 throughout the nucleus that accompanied a loss of localization to heterochromatic foci, supporting the impaired binding of mutant MeCP2 to mCpGs in vivo (Fig. 1d) . Streptavidin IF, which was lower in Mecp2-mutant than in TAVI mice, also confirmed a loss of mutant MeCP2 localization to heterochromatic foci and further illustrated a redistribution of mutant MeCP2 to the nucleolus ( Fig. 1d and Supplementary Fig. 2b,c) , a property reminiscent of GFP-tagged MeCP2 lacking its MBD 33 .
Using subnuclear fractionation from whole-brain samples, we confirmed that a greater proportion of MeCP2 T158M or R106W occupied the soluble fraction than MeCP2 WT or TAVI protein ( Supplementary Fig. 2d) , consistent with the loss of chromatin binding in mutant mice (Fig. 1d) . When we further extracted chromatin-bound MeCP2 with different salt concentrations, we found that MeCP2 R106W was more readily released at lower salt concentrations (200 mM NaCl) than WT, TAVI or T158M MeCP2, suggesting that MeCP2 R106W has the lowest binding affinity for chromatin ( Fig. 1f and Supplementary Fig. 2e ). Phenotypic comparisons revealed that T158M and R106W mice exhibit RTT-like features similar to those of Mecp2-knockout mice, including decreased brain and body weight, and age-dependent increase in phenotypic score ( Fig. 1g-i) .
Although lifespan was significantly reduced in all three Mecp2 mutants, the median survival of R106W mice was more similar to that of Mecp2-knockout than T158M mice (Fig. 1j) . The mutants showed a significant difference in survival (T158M median survival = 14 weeks; R106W median survival = 10 weeks; Mantel-Cox P = 0.012). Together, these data suggest that T158M and R106W mutations represent a partial and complete loss of function, respectively.
Genetic biotinylation permits transcriptional profiling
We next devised a biotinylation-based strategy for cell-type-specific nuclear isolation and transcriptional profiling ( Fig. 2a,b) . We used the NeuroD6/NEX-Cre mouse line 34 to drive BirA expression and MeCP2-Tavi biotinylation in forebrain excitatory neurons (Mecp2 Tavi/y ; R26 cBirA/+ ;NEX Cre/+ , herein NEX-Cre) ( Fig. 2a and Supplementary Fig. 3a-g) . Quantification of pan-neuronal (NeuN), pan-inhibitory (GAD67) and inhibitory-specific (parvalbumin, somatostatin and calretinin) neuronal markers in the somatosensory cortex of NEX-Cre mice showed that biotinylation occurred in ~80% of NeuN + cortical neurons devoid of inhibitory markers (Supplementary Fig. 3h ). FACS analysis of cortical nuclei from NEX-Cre mice identified three distinct nuclear populations ( Fig. 2c) . RT-PCR for cell-type-specific markers confirmed that NeuN + biotin + nuclei reflect excitatory neurons, whereas NeuN + biotin − nuclei represent a mixture of inhibitory interneuron subtypes (Fig. 2c,d) . Astrocytic, microglial and oligodendrocytic markers were restricted to a third, non-neuronal population of NeuN − biotin − nuclei (Fig. 2c,d) . We also used the Dlx5/6-Cre line 35 to drive BirA expression in forebrain GABAergic neurons and obtained results inverse to those from NEX-Cre mice ( Fig. 2a and  Supplementary Fig. 3a-j) , confirming that MeCP2-Tavi is reliably biotinylated in Cre-defined cell types.
MeCP2 modulates transcription 21 , so nuclear RNA-seq would afford an unique opportunity to study the primary effects of RTT-associated a r t i c l e s nature medicine VOLUME 23 | NUMBER 10 Fig. 2e ). n replicates = 4-5, one-way ANOVA. (g) Brain weights from untagged and tagged 6-week-old male mice (n WT = 20, n TAVI = 11, n KO = 6, n T158M = 6, n R106W = 12; one-way ANOVA). Box limits, interquartile range; center line, median; +, mean; whiskers, maximum and minimum values. (h) Body weight over postnatal age in untagged and tagged male mice. Data points represent the average of at least 6 observations each.n WT = 31, n TAVI = 23, n KO = 15, n T158M = 14, n R106W = 28. (i) RTT-like phenotypic score across postnatal development. Data points consist of the average of at least 6 observations each. n WT = 31, n TAVI = 23, n KO = 15, n T158M = 14, n R106W = 28. (j) Kaplan-Meier survival curves for untagged (WT, KO) and tagged (TAVI, T158M, R106W) male mice (n WT = 31, n TAVI = 23, n KO = 17, n T158M = 39, n R106W = 26). *P < 0.5, **P < 0.01, ***P < 0.001, ****P < 0.0001, n.s., not significant; all data are mean ± s.e.m. unless stated otherwise (see also a r t i c l e s nature medicine VOLUME 23 | NUMBER 10 | OCTOBER 2017 mutations on gene expression. We thus performed transcriptional profiling in male mice at 6 weeks of age, near the onset of their RTTlike phenotypes. We employed the NeuroD6/NEX-Cre mouse line to isolate cortical excitatory and inhibitory nuclei from T158M, R106W and TAVI mice via FACS, followed by total RNA-seq ( Supplementary  Table 1 ). Biological replicates were well correlated ( Fig. 2e) , and ~74% of total reads mapped to introns, serving as a proxy for chromatinassociated transcriptional activity 36, 37 . Unsupervised hierarchical clustering shows that replicate transcriptomes from cortical excitatory and inhibitory neurons in TAVI mice are highly correlated by cell type, and genic-mapped reads illustrate selectively expressed genes in each cell type ( Fig. 2e,f and Supplementary Fig. 4a ). We identified 9,379 differentially expressed genes (DEGs, false discovery rate (FDR) < 0.05) between excitatory and inhibitory neurons, the majority (86.9%) of which comprise protein-coding genes ( Table 1 and Supplementary  Fig. 4b ). Among the protein-coding fraction of cell-type-enriched DEGs, 3,958 genes (0.15-4.70-fold change) showed Gene Ontology (GO) functions consistent with glutamatergic pyramidal cell types (EXC-enriched) ( Supplementary Fig. 4c ), whereas the remaining 4,194 genes (0.17-7.77-fold change) showed GO functions consistent with metabolically active GABAergic interneurons (INH-enriched) ( Supplementary Fig. 4d ).
Protein-coding genes are more affected in R106W mice
We next compared nuclear gene-expression profiles in excitatory and inhibitory neurons between mutant (T158M, R106W) and control (TAVI) mice to identify and characterize DEGs associated with the appearance of RTT-like phenotypes ( Fig. 3a) . We identified more DEGs in excitatory and inhibitory neurons of R106W than T158M mice, indicating that the number of misregulated genes positively scales with the increased molecular and phenotypic severity of the Mecp2 mutation ( Fig. 3b and Table 1 ). More than 90% of either T158M-or R106W-associated DEGs were protein-coding genes ( Supplementary Fig. 5a ), substantially higher than the percentage of protein-coding genes in the genome (60.4%) and among actively expressed (77.7-78.3%) and celltype-enriched (86.2-87.7%) genes ( Supplementary Fig. 4b ). We therefore excluded noncoding genes from further analyses. We note that between T158M and R106W genotypes, there were more overlapping protein-coding DEGs in inhibitory neurons (107 genes) than in excitatory neurons (69 genes). Moreover, DEGs shared between genotypes tended to be misregulated in the same direction (Fig. 3c) .
The median fold change among both T158M and R106W DEGs was small when compared to overall differences in gene expression between excitatory and inhibitory neurons ( Supplementary Fig. 5b and Table 1 ). We further compared fold changes between T158M and R106W DEGs, limiting our analysis to protein-coding genes that overlap between genotypes to account for disproportionate numbers of DEGs. Within this subset, we found that the median fold change among upregulated and downregulated DEGs was higher in cells from R106W mice than those from T158M mice ( Fig. 3c) , consistent with a more severe phenotype in R106W mice.
Transcriptional features of T158M and R106W DEGs
We next compared T158M-or R106W-associated DEGs across excitatory and inhibitory neurons and found limited overlap between the two cell types (6.2% of T158M DEGs, 10.7% of R106W DEGs) ( Fig. 3d) , indicating that most DEGs reflect cell-type-specific transcriptional changes. Indeed, EXC-and INH-enriched genes were significantly overrepresented among both T158M and R106W DEGs a r t i c l e s nature medicine VOLUME 23 | NUMBER 10 | OCTOBER 2017 1 2 0 9
in each cell type, comprising ~70-80% of genes ( Fig. 3e and Table 1) . Moreover, EXC-and INH-enriched genes were preferentially downregulated and upregulated, respectively, in each cell type ( Fig. 3e and Supplementary Fig. 5c ). We next performed a pre-ranked gene set enrichment analysis (GSEA, FDR < 0.1) to determine whether upregulated and downregulated DEGs represent functionally distinct categories. DEGs upregulated in T158M and R106W mice were primarily associated with transcriptional regulation. These included genes encoding DNAbinding transcriptional activators, repressors and chromatin remodelers, most of which tend to be INH-enriched genes ( Fig. 3f and Supplementary Fig. 5d ). Functional categories significantly associated with downregulated DEGs, however, were detected specifically in R106W excitatory neurons and enriched for post-synaptic membrane proteins, including various ion channels, synaptic scaffolding proteins and ionotropic glutamate receptors ( Fig. 3f) . Although significantly associated gene functions were not identified among downregulated DEGs in inhibitory neurons using our GSEA FDR cutoff, gene functions associated with upregulated DEGs in R106W inhibitory neurons were related to cellular metabolism and signal transducer activity ( Supplementary Fig. 5e ).
Upon examining the relative expression level (measured as fragments per kilobase of transcript per million mapped reads (FPKM)) of T158M and R106W DEGs, we noticed that these DEGs, as well as DEGs overlapping between the two genotypes, showed significantly lower FPKM values than total expressed genes in each cell type ( Fig. 3g) . To exclude the possibility of gene filtering biases associated with RNA-seq, we randomly selected 12 low-expressing DEGs shared between both mutants and independently measured primary and mature RNA transcripts in excitatory neuronal nuclei by RT-PCR (Supplementary Table 2 ). We found that 10 out of 12 genes showed significant gene-expression changes that resembled those using RNAseq (unpaired Student's t-test, two-tailed P < 0.05; 83.3% positive validation rate) ( Supplementary Fig. 6a,b) , confirming that genes with low transcriptional activity are affected by MeCP2 mutations. To examine whether lowly expressed genes were selectively enriched for either T158M or R106W DEGs, we binned actively expressed genes from each cell type into four percentiles (Q1-Q4) according to expression level. EXC-and INH-enriched genes served as reference distributions across percentiles for each cell type ( Supplementary  Fig. 6c ). T158M and R106W DEGs were preferentially enriched in Q1, the bottom twenty-fifth percentile of actively expressed genes, in both excitatory and inhibitory neurons (Fisher's exact one-tailed P = 1.11 ×10 −7 (T158M EXC), 2.03 × 10 −4 (T158M INH), 4.04 × 10 −8 (R106W EXC), 1.50 × 10 −2 (R106W INH)) ( Supplementary Fig.  6c ). Between the two mutants, T158M DEGs were more likely to be lowly expressed than R106W DEGs (Fisher's exact odds ratio (OR) for Q1 = 3.1 (T158M EXC), 3.2 (T158M INH); 2.0 (R106W EXC), 1.3 (R106W INH)) ( Supplementary Fig. 6c ). Accordingly, R106W DEGs showed significantly higher FPKM values than T158M DEGs in both cell types and were predominantly downregulated in R106W neurons ( Fig. 3g and Supplementary Fig. 6d ). This preferential downregulation of high-expressing genes appears consistent with the specific loss of synaptic gene functions in R106W excitatory neurons ( Fig. 3f,g and Supplementary Fig. 6d ).
Subcellular RNAs reveal post-transcriptional changes in RTT
Two recent reports implicate MeCP2 in the transcriptional repression of long genes, which are preferentially upregulated in the neurons of multiple RTT models 26, 38 . We therefore sought to determine whether genome-wide transcriptional changes correlate with the differences in phenotypic and molecular severity exhibited between both RTT variants. Similarly to those studies, we sorted and binned expressed protein-coding genes according to gene length and measured the mean fold change in Mecp2-mutant neurons. Notably, nuclear transcriptomes revealed an inversion of previously reported geneexpression changes whereby short (≤100 kb in length) and long (>100 kb) genes trend toward upregulation and downregulation, respectively, in a length-dependent manner (Supplementary Fig. 7a) .
Although most nuclear RNAs comprise intron-containing pre-mRNA transcripts on chromatin, the presence of processed mRNA transcripts awaiting nuclear export may potentially confound the assessment of transcriptional events 39 . We therefore performed global nuclear run-on with high-throughput sequencing (GRO-seq) 40 to directly assess de novo transcriptional activity by RNA polymerase in cortical nuclei of TAVI and R106W mice. Similarly to sorted nuclear RNA, the nascent transcription of short and long genes was predominantly increased and decreased, respectively, in R106W neurons ( Fig. 4a) . LOESS local regression of DEGs that were identified in R106W excitatory and inhibitory neurons also revealed a similar overall trend toward preferential downregulation of long genes (Fig. 4a) . The genome-wide trend we observed in sorted nuclear RNA thus represents a primary effect at the transcriptional level, prompting us to further investigate whether the length-dependent upregulation of long genes reported previously may represent an indirect effect of MeCP2-dependent transcriptional deregulation. To test this, we resected cortical tissue from TAVI and R106W mice and subjected each cortical half to whole-cell or nuclear RNA isolation in parallel, followed by sequencing. Cortical whole-cell RNA from mutant mice showed a length-dependent increase in the mean expression of long genes (Fig. 4b) , similarly to what was previously described 26, 38 . In contrast, cortical nuclear RNA isolated from the same TAVI and R106W mice exhibited length-dependent upregulation of short genes and downregulation of long genes (Fig. 4c) , corroborating the transcriptional changes we observed in nascent RNA ( Fig. 4a ) and nuclear RNA from sorted nuclei ( Supplementary Fig. 7a ). Using the 10,390 expressed genes associated with de novo transcription by GRO-seq ( Fig. 4d) , we observed that genes upregulated in nascent and nuclear RNA pools were cumulatively shorter in length than those upregulated in whole-cell RNA, and the inverse was true among downregulated genes ( Fig. 4e) . Thus, gene-expression changes in Mecp2-mutant neurons appear to be substantially different between subcellular compartments.
To directly compare individual genes across subcellular compartments, we next classified all 10,390 expressed genes into eight subgroups (groups A-H), which reflect the total number of arrangements by which a gene can be misregulated across three given RNA pools (2 3 = 8). Groups B and D comprise 38.4% of expressed genes involved in neuronal projection and cellular stress, respectively, and represent expression changes that are misregulated in the same direction across nascent, nuclear and whole-cell RNA pools ( Fig. 4f and Supplementary Fig. 7b ). Among these groups of genes, log 2 fold changes measured from the whole cell were significantly smaller than those in the nuclear compartment, suggesting that gene-expression changes in the nucleus are post-transcriptionally minimized in the cell ( Fig. 4f and Supplementary Fig. 7c) . The majority of genes (48%), however, exhibited expression changes in nascent RNAs that were reversed in the whole-cell compartment (groups A, C, G and H) ( Fig. 4f) . Groups A and C consist of relatively long, EXC-enriched genes that are transcriptionally downregulated in nascent RNA but a r t i c l e s post-transcriptionally upregulated in whole-cell RNA ( Fig. 4f and Supplementary Fig. 7d,e ). DAVID gene ontology revealed that group A genes are associated with synaptic functions and intracellular signaling ( Fig. 4g) . Groups G and H consist of considerably shorter, INH-enriched genes that are transcriptionally upregulated in nascent RNA but post-transcriptionally downregulated in whole-cell RNA ( Fig. 4f and Supplementary Fig. 7d,e) , and group G genes are functionally associated with cellular energy and metabolism in mitochondria ( Fig. 4g) . RT-PCR validation of primary and mature RNA transcripts for several genes from groups A, C, B, and D recapitulated these apparent expression differences between subcellular compartments, particularly when gene groups were analyzed as a collective in their respective gene group (Fig. 4h, Supplementary Fig. 8 and Supplementary Table 2) .
Notably, upon analyzing de novo transcriptional activity derived . Data represent DEGs that overlap between T158M and R106W mice (n = 185). Nodes denote functional categories, colored by normalized enrichment score (NES). Line weight denotes extent of gene overlap between connected nodes. *P < 0.5, **P < 0.01, ***P < 0.001, ****P < 0.0001, n.s., not significant (see also Supplementary Fig. 10 and Online Methods).
a r t i c l e s from GRO-seq for genes expressed in sorted excitatory or inhibitory neurons (Supplementary Fig. 7f ), we found a trend toward long genes being more severely downregulated in cell types bearing the R106W mutation than those with the T158M mutation ( Fig. 4i and Supplementary Fig. 7g) , consistent with a more severe phenotype in R106W mice.
To gain insight into the apparent switch in gene misregulation between subcellular compartments, we next used publicly available data sets from high-throughput sequencing of RNA isolated by crosslinking immunoprecipitation (HITS-CLIP) experiments in mouse brain ( Supplementary Table 3 ) to examine genes whose transcripts are typically bound and regulated by RNA-binding proteins (RBPs) and tested for associations with distinct subcellular gene expression changes in Mecp2-mutant neurons. K-means clustering of 10,390 cortically expressed genes across HITS-CLIP data for 12 RBPs (MBNL1 and MBNL2, TDP43, FUS, TAF15, FMR1, HuR, APC, RBFOX1, RBFOX2, RBFOX3 and AGO2) identified five major gene clusters (Supplementary Fig. 9a ). We found one subset of genes whose transcripts showed a significantly higher frequency of HuR binding (Wilcoxon rank sum test, one-tailed P cluster 1 = 1.68 × 10 −13 , P cluster 4 = 2.01 × 10 −110 ) and lower frequency of AGO2 binding (one-tailed P cluster 1 = 7.01 × 10 −33 , P cluster 4 = 1.70 × 10 −9 ) (RBP clusters 1 and 4), and another subset showing a significantly higher frequency of AGO2 binding (one-tailed P cluster 2 = 8.47 × 10 −33 , P cluster 3 = 4.86 × 10 −32 , P cluster 5 = 6.18 × 10 −216 ) but a lower frequency of HuR binding (onetailed P cluster 2 = 7.89 × 10 −255 , P cluster 3 = 1.16 × 10 −13 , P cluster 5 = 1.82 × 10 −286 ) (RBP clusters 2, 3 and 5) ( Supplementary Fig. 9b,c) . HuR binds to the 3′ UTR of mRNA transcripts (Supplementary Fig. 9d ) and increases mRNA stability 41 . Conversely, AGO2 promotes mRNA degradation through AGO2-bound microRNAs (miRNAs) 42 . The genes encoding HuR and AGO2 are also actively expressed in neurons of mice at 6 weeks of age (Supplementary Fig. 9e ). When we compared gene groups A-H, which summarize subcellular gene expression changes in Mecp2-mutant neurons (Fig. 4f) , to functionally distinct RBP clusters (Supplementary Fig. 9a-c) , we found that many downregulated nascent RNA transcripts from groups A, B and C were significantly associated with RBP clusters 1 and 4 (Fisher′s exact one-tailed P < 0.05) and are probable post-transcriptional targets of HuR (Supplementary Fig. 9f ). By contrast, upregulated nascent RNA transcripts in Mecp2-mutant neurons, particularly from groups G and H, showed associations with RBP clusters 2, 3 and 5 (Fisher′s exact one-tailed P < 0.05), and are probable targets of AGO2-bound miR-NAs (Supplementary Fig. 9f) . The opposite functions of HuR and AGO2 in the post-transcriptional regulation of mRNA stability likely alter the abundance of cellular RNAs in a group-or cluster-specific manner. Therefore, gene-expression differences between subcellular compartments in Mecp2-mutant mice could be mediated posttranscriptionally in part by RBPs (Supplementary Fig. 9g ).
Female RTT mice exhibit cell-and non-cell-autonomous DEGs
RTT is an X-linked disorder that primarily affects heterozygous females. However, the extent to which intermixed Mecp2 WT and mutant (MUT) neurons in cellular mosaic RTT females affect each other at the level of gene expression remains unknown. The reduced expression of T158M and R106W proteins allowed us to use the same tagging and sorting strategy in male mice to isolate and profile WT (denoted by subscript: T158M WT , R106W WT ) and MUT (T158M MUT , R106W MUT ) cells from mosaic female mice. These include Mecp2 Tavi/+ ; R26 cBirA/+ ;NEX Cre/+ (TAVI), Mecp2 Tavi/T158M-Tavi ;R26 cBirA/+ ;NEX Cre/+ (T158M) and Mecp2 Tavi/R106W-Tavi ;R26 cBirA/+ ;NEX Cre/+ (R106W) heterozygous female mice that each carry a Tavi-tagged WT allele and a Tavi-tagged T158M, R106W or untagged WT allele. When T158M and R106W female mice reached ~18 weeks of age and exhibited RTT-like phenotypes (Fig. 5a) , we isolated cortical excitatory nuclei for FACS (Fig. 5b,c and Supplementary Fig. 10a ). From the number of females sampled, we did not detect skewed X-chromosome inactivation (>75%) among excitatory neurons in TAVI, T158M or R106W mice (Fig. 5d) .
By comparing the gene-expression profiles of WT or MUT neurons from heterozygous mutant mice to those from control mice (TAVI WT ), we identified a total of 526 unique protein-coding DEGs from both T158M WT and T158M MUT neurons, and 678 unique protein-coding DEGs from both R106W WT and R106W MUT neurons ( Fig. 5e,  Supplementary Fig. 10b and Table 1 ). Most DEGs represent cellautonomous gene-expression changes that occur in mutant neurons alone ( Fig. 5e) . However, a larger proportion (43.4%) of R106W DEGs were also found in R106W WT neurons (Fig. 5e) , revealing a mutation-specific susceptibility of WT neurons to non-cell-autonomous gene-expression changes in heterozygous females. Using principal component analysis (PCA) to plot the first two major axes (PC1 and PC2) of transcriptome variation, we found that PC2 separated neuronal populations by Mecp2 allele status (WT versus MUT neurons) irrespectively of mutation ( Fig. 5f) , indicating that Mecp2 mutations induce cell-autonomous changes that make MUT neurons transcriptionally distinct from neighboring WT neurons. However, PC1 accounts for nearly twice the variation of PC2 and clusters R106W WT and R106W MUT populations away from other genotypes, probably because of the extensive number of indirect DEGs associated with this mutation. In contrast, against PC1 and PC2, T158M WT neurons closely resembled TAVI WT (Fig. 5f) , indicating that the non-cell-autonomous DEGs observed in R106W WT neurons arise specifically due to the more severe effect of the R106W mutation in R106W MUT neurons.
We found 194 DEGs that overlap between T158M and R106W female mice, most of which were misregulated in the same direction ( Fig. 5g) . Cell-autonomous transcriptional changes (149 genes, 76.8%) were more likely to be shared between Mecp2 variants than non-cell-autonomous changes (9 genes, 4.6%) (Fig. 5h) . These overlapping DEGs also showed higher fold changes in R106W than in T158M female mice, but this difference was driven mainly by noncell-autonomous DEGs in R106W neurons (Fig. 5i) .
In R106W female mice, we found that non-cell-autonomous DEGs were predominantly upregulated (~60%), in contrast to cellautonomous DEGs (~48%) (Supplementary Fig. 10b) , and display significantly higher fold changes than cell-autonomous DEGs (Supplementary Fig. 10c ). Furthermore, cell-autonomous DEGs were considerably longer, specifically among upregulated genes (Supplementary Fig. 10d) . To determine whether cell-and noncell-autonomous DEGs represent distinct biological processes, we also performed pre-ranked GSEA (FDR < 0.1) and found that noncell-autonomous gene-expression changes primarily affected cellto-cell signaling and negative regulation of protein phosphorylation (Supplementary Fig. 10e ). These DEGs included several immediate early and late response genes that are induced by neuronal activity and modulate signaling pathways associated with synaptic plasticity 43 . In contrast, cell-autonomous DEGs were significantly associated with transcriptional regulation (Supplementary Fig. 10f) . These functional categories demonstrate a marked resemblance to those observed in excitatory neurons of male T158M and R106W mice (Fig. 5j) . The consistency with which these functional annotations characterized Mecp2-mutant neurons despite differences in mouse age a r t i c l e s nature medicine VOLUME 23 | NUMBER 10 | OCTOBER 2017 1 2 1 3
and sex supports the cell-autonomous disruption of these functions as a key, contributing factor to RTT pathogenesis.
DISCUSSION
The complexity of MeCP2 molecular function, coupled with the cellular heterogeneity of the brain, confounds the study of transcriptional changes in RTT. We thus combined in vivo biotinylation with Cre-loxP technology to label both WT and mutant MeCP2 from different neuronal populations and examine RTT-associated transcriptomes in mice. Notably, the 23-aa Tavi tag can be readily used to target a given protein using CRISPR-Cas9 technology 44 for cell-type-specific biochemical purifications, molecular profiling and imaging applications. By using an allelic series of RTT-associated mutations to perform a transcriptome analysis of cortical neurons, we identified similarities and differences in gene-expression features that couple MeCP2 DNA-binding ability to RTT phenotypic severity. We found that lowly expressed, cell-type-enriched genes are sensitive to the effects of both T158M and R106W mutations, which likely contributes to the specificity of MeCP2-mediated gene-expression changes among different neuronal cell types. Both mutations display conserved transcriptional features among upregulated DEGs in male and female neurons, which include genes encoding INH-enriched transcription factors and chromatin remodelers. The upregulation of transcriptional regulators could contribute to the shared RTT etiology between T158M and R106W mice, as well as the genome-wide trend toward increased transcription of shorter, INH-enriched genes associated with cellular respiration and energy metabolism. This provides transcriptional insight into clinical features among both mildly and severely affected RTT patients that resemble mitochondrial and metabolic disorders 45 .
The greater impairment in MeCP2 R106W binding to neuronal chromatin is associated with increased RTT phenotypic severity and notably correlates with the larger number and degree of misregulated genes that are more highly expressed and predominately downregulated relative to the T158M mutation. These transcriptional differences extend to most long genes throughout the genome, which are also known to be highly expressed in neurons 46 . Our data sets are in partial agreement with global reductions in RNA polymerase phosphorylated at Ser5 in Mecp2-knockout neuronal nuclei 47 , supporting MeCP2 as a global modulator of gene transcription. Loss of MeCP2 occupancy may either alter local chromatin organization, which could decrease the efficiency of transcriptional elongation 48 and lead to the downregulation of long genes, or abrogate HDAC3-mediated recruitment of transcription factors required for long gene transcriptional activation 49 . Because downregulated genes associate with synaptic morphology and function and R106W mice have shorter lifespans than T158M mice, reductions in long gene transcription may act as modifiers to worsen RTT-like phenotypes. RTT patients with mutations that preserve MeCP2 binding show milder features than patients for whom binding is disrupted 12 . Transcriptional assessments with mutations preserving MeCP2 binding are thus necessary to further refine these genotype-phenotype correlations.
Because MeCP2 is a DNA-binding nuclear protein 21 , nuclear and nascent RNA pools provide additional insights into the primary effects of RTT-associated mutations on transcriptional activity 36, 37, 50 that complement the reported whole-cell upregulation of long genes in RTT 26, 38 . Whole-cell RNA is subject to post-transcriptional regulation 39, 51, 52 , being notably enriched for cytoplasmic mRNAs that are bound by various RBPs to modulate their steady-state abundance and turnover. We found that many downregulated nascent RNA transcripts are targets of HuR, which increases mRNA stability in the brain 41 and may post-transcriptionally upregulate these transcripts in whole-cell RNA. Upregulated nascent RNA transcripts tend to associate with miRNA-bound AGO2, which may post-transcriptionally mitigate their upregulation by increasing rates of mRNA decay 42 . These posttranscriptional mechanisms may abate cellular consequences arising from global alterations in synaptic, mitochondrial, and metabolic gene transcription. Whole-cell gene-expression changes in RTT may thus be compensatory and not entirely representative of transcriptional activity, questioning the therapeutic benefit of decreasing long gene transcription for treating RTT. Identifying RBPs that contribute to cellular compensation may yield a novel class of interventional therapies administered before or during the initial phases of RTT, minimizing its pathological impact.
Finally, our approach allows the molecular profiling of mosaic neurons from female mice that represent accurate preclinical RTT models, revealing non-cell-autonomous changes in WT neurons that depend on mutation severity. However, to better elucidate direct and indirect contributions to RTT, further investigation requires examination of females with a wide range of XCI ratios across multiple ages, cell types and Mecp2 mutations. Non-cell-autonomous DEGs include genes induced by neuronal activity to reduce synaptic responsiveness to excessive neuronal stimuli 43 . Nuclear RNA transcripts of two late-response genes in particular, Bdnf and Igf1, were transcriptionally upregulated in WT and MUT neuronal nuclei of 18-week-old R106W female mice (Supplementary Fig. 10e) . As Bdnf and Igf1 encode neuroprotective peptides that ameliorate RTT symptoms 19 , the selective upregulation of non-cell-autonomous DEGs in R106W mice may be a protective response to increased neuronal activity or stress among severely affected mosaic neurons. Currently, BDNF and IGF-1 peptides are being tested in clinical trials 53, 54 . Further study of molecular pathways associated with non-cell-autonomous DEGs may thus reveal additional RTT therapeutic targets and avenues. 
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ONLINE METHODS
Generation of mouse lines. The targeting construct used for homologous recombination at the Mecp2 locus in murine embryonic stem (ES) cells was cloned in two arms by PCR amplification of sv129 genomic DNA. The 5′ arm was PCR amplified with 5′-AGGAGGTAGGTGGCATCCTT-3′ and 5′-CGTTTGATCACCATGACCTG-3′ primers, whereas the 3′ arm was PCR amplified with 5′-GAAATGGCTTCCCAAAAAGG-3′ and 5′-AAAACGGCACCCAAAGTG-3′ primers. Restriction sites at the ends of each arm were created using nested primers for cloning into a vector containing a loxP-flanked ('floxed') neomycin cassette (Neo) and a diphtheria toxin A negative-selection cassette. QuikChange (Stratagene) insertional mutagenesis was used to generate the Mecp2 Tavi targeting construct by inserting the Tavi tag immediately upstream of the Mecp2 stop codon within the 5′ arm. The portion of the Tavi tag containing the biotinylation consensus sequenced flanked by 5′ NaeI and 3′ BspHI restriction sites was inserted through two rounds of mutagenesis: Round 1 forward: 5′-GACCGAGAGAGTTAGCGCCGGCCTGAACGACA TCTTCGAGTCATGACTTTACATAGAGCG-3′ Round 1 reverse: 5′-CGCTCTATGTAAAGTCATGACTCGAAGATGTCG TTCAGGCCGGCGCTAACTCTCTCGGTC-3′ Round 2 forward: 5′-CTGAACGACATCTTCGAGGCTCAGAAAATCGA ATGGCACGAATCATGACTTTACATAGAG-3′ Round 2 reverse: 5′-CTCTATGTAAAGTCATGATTCGTGCCATTCGATT TTCTGAGCCTCGAAGATGTCGTTCAG-3′
The portion of the tag containing the TEV protease cleavage site was inserted upstream of the NaeI restriction site with a third round of mutagenesis: Round 3 forward: 5′-GACCGAGAGAGTTAGCGAAAACCTGTATTTTC AGGGCGCCGGCCTGAACGACATC-3′ Round 3 reverse: 5′-GATGTCGTTCAGGCCGGCGCCCTGAAAATACAGGTTTTCGCTAAC TCTCTCGGTC-3′
To generate Mecp2 Tavi targeting constructs bearing independent RTT-associated point mutations, QuikChange site-directed mutagenesis was used to mutate MeCP2 Arg106 to tryptophan and MeCP2 Thr158 to methionine within the 3′ arm and 5′ arm, respectively. A single nucleotide at codon T160 also underwent site-directed mutagenesis for a silent mutation to introduce a BstEII restriction site to correctly identify targeted ES cells.
To generate conditional R26 cBirA transgenic mice, PCR primers containing AscI restriction sites and a Kozak consensus sequence were used to subclone the BirA coding sequence and insert it downstream of both a CAG promoter and a floxed transcriptional attenuator, Neo-STOP, within pROSA26-1, a transgenic targeting vector that has previously been characterized 55 .
After confirmation by Sanger sequencing and linearization with NotI (Mecp2 Tavi targeting construct and its mutant variants) or SgfI (cBirA targeting construct), the constructs were electroporated into sv129-derived murine ES cells. Correctly targeted ES cells were independently injected into C57BL/6 blastocysts and subsequently implanted into pseudopregnant females. Agouti offspring were screened by Southern blot and PCR genotyping to confirm germline transmission of the Mecp2 Tavi , Mecp2 T158M-Tavi , Mecp2 R106W-Tavi , and R26 cBirA alleles. In the case of the Mecp2 Tavi allele and its mutant variants, the resulting offspring were mated with C57BL/6 EIIa-cre mice to ensure germline deletion of the floxed Neo cassette between Mecp2 exons 3 and 4.
Additional mouse lines. Dlx5/6-Cre (stock #008199) and EIIa-Cre (stock #003724) mice were obtained from the Jackson Laboratory 30, 35 . NeuroD6/NEX-Cre mice were obtained with permission from K.-A. Nave's laboratory (Max Planck Institute of Experimental Medicine) 34 .
Animal husbandry. Experiments were conducted in accordance with the ethical guidelines of the US National Institutes of Health and with the approval of the Institutional Animal Care and Use Committee of the University of Pennsylvania. All of the experiments described were performed using mice on a congenic sv129:C57BL/6J background with the knock-in/transgenic alleles backcrossed to C57BL/6J mice (Jackson Laboratory) for at least five generations, unless otherwise stated. Mice were housed in a standard 12-h light-12-h dark cycle with access to ample amounts of food and water. Mice bearing the Tavi tag were genotyped using a bipartite primer PCR-based strategy to detect the Tavi tag at the 3′ end of the endogenous Mecp2 gene (forward: 5′-CACCCCGAAGCCACGAAACTC-3′, reverse: 5′-TAAGACTCAGCCTATGGTCGCC-3′) and give rise to a 318bp product from the wild-type allele and a 388-bp product from the tagged allele. Mice bearing the BirA transgene were genotyped using a tripartite primer PCR-based strategy to detect the presence or absence of the CAG promoter at the Rosa26 locus (forward:5′-TGCTGCCTCCTGGCTTCTGAG-3′, reverse #1: 5′-GGCGTACTTGGCATATGATACAC-3′, reverse #2: 5′-CACCTGTTCAATTCCCCTGCAG-3′) and give rise to a 173-bp product from the wild-type allele and a 477-bp product from the transgene-bearing allele. Mice bearing Cre-recombinase (either NeuroD6/NEX-Cre or Dlx5/6-Cre) were genotyped using PCR-based strategies as previously described 34, 35 .
Phenotypic assessment. For tagged Mecp2 knock-in mice, phenotypic scoring was performed on a weekly basis for the presence or absence of overt RTTlike symptoms as previously described 32 . Investigator was blinded to genotypes during phenotypic assessment of mice. For BirA transgenic mice, no formal scoring was performed. However, R26 BirA heterozygous and homozygous mice are viable, fertile, and devoid of any gross abnormalities, consistent with previously engineered transgenic mice that express BirA either ubiquitously or within restricted tissues using cell-type-specific promoters 56, 57 .
Immunofluorescence and microscopy. Mice were anesthetized with 1.25% avertin (wt/vol), transcardially perfused with 4% paraformaldehyde (wt/vol) in 0.1 M sodium-potassium PBS and post-fixed overnight at 4 °C. Brains were coronally or sagittally sectioned at 20 µm using a Leica CM3050 S cryostat. Immunofluorescence on free-floating sections was performed as previously described 17 , except sections were permeabilized with 0.5% Triton without methanol for 20 min, and sections were blocked overnight with 10% NGS and 1:100 unconjugated goat anti-mouse IgG (Sigma M5899). The following primary antibodies were incubated at 4 °C overnight: rabbit anti-MeCP2 C terminus (1:1,000, in house), rabbit anti-nucleolin (1:1,000, Abcam ab22758), mouse anti-parvalbumin (1:500, Millipore MAB1572), rabbit anti-calretinin (1:1,000, Swant 7699/3H), mouse anti-GAD67 (1:500, Millipore MAB5406), mouse anti-NeuN (1:500, Millipore MAB377). For rat anti-somatostatin (1:250, Millipore MAB354MI), primary incubation was performed for 48 h at 4 °C. Fluorescence detection of primary antibodies was performed using Alexa 488-conjugated goat anti-rabbit (1:1,000, Invitrogen A11008), Alexa 488-conjugated goat anti-mouse (1:1,000, Invitrogen A11029), or Alexa 488 goat anti-rat (1:1,000, Invitrogen A11006). Fluorescence detection of biotin was performed simultaneously with Streptavidin Dylight 650 (1:1000, Fisher 84547) for fluorescence microscopy and Streptavidin Dylight 550 (1:1000, Fisher 84542) for confocal microscopy. Sections were counterstained with DAPI (1:1000, Affymetrix 14564) to visualize DNA before mounting with Fluoromount G (SouthernBiotech). Images were acquired using a Leica DM5500B fluorescent microscope with a Leica DFC360 FX digital camera (region-specific biotinylation, quantification of neuronal cell-type-specific markers) or a Leica TCS SP8 Multiphoton confocal microscope (representative images of neuronal cell type specific markers, subcellular localization of MeCP2). Images were acquired using identical settings for laser power, detector gain amplifier offset and pinhole diameter in each channel. Image processing was performed using ImageJ and Adobe Photoshop, including identical adjustments of brightness, contrast, and levels in individual color channels and merged images across genotypes.
Quantitative western blot analysis. Quantitative western blot was performed using Odyssey Infrared Imaging System (Licor). Primary antibodies used in this study include rabbit anti-MeCP2 C terminus (1:4,000, in house), mouse anti-MeCP2 N terminus (1:4,000, Sigma M7433), mouse anti-NeuN (1:500, Millipore MAB377), rabbit anti-Avi tag (1:5,000, Abcam ab106159, listed as anti-Tavi in main text, detects the minimal peptide substrate of biotin ligase BirA regardless of biotinylation status), rabbit anti-HDAC3 (1:1,000, Santa Cruz sc-11417), rabbit anti-TBLR1 (1:1,000, Bethyl A300-408A), rabbit anti-Sin3A, (1:500, Thermo Scientific PA1-870), rabbit anti-histone H3 (1:1,000, Abcam ab1791), and rabbit anti-TBP (1:1,000, Cell Signaling #8515). Secondary antibodies include antirabbit IRDye 680LT (1:10,000, Licor), anti-mouse IRDye 800CW (Licor), streptavidin Dylight 650 (1:10,000, Fisher 84547) and Streptavidin Dylight 800 (1:10,000, Fisher 21851). Quantification of protein expression was carried out following Odyssey Infrared Imaging System protocols. Scans of full-length western blot membranes are provided in Supplementary Figures 11-13 . Coimmunoprecipitation using nuclear extracts. Tissues were mined on ice and homogenized in ice-cold lysis buffer (10 mM HEPES, pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 0.5% NP-40, 0.2 mM EDTA, protease inhibitors). Nuclei were pelleted, washed and resuspended in nuclear extract (NE) buffer (20 mM HEPES, pH 7.9, 1.5 mM MgCl 2 , 500 mM KCl, 0.2 mM EDTA, 10% glycerol, protease inhibitors). Nuclei were incubated in NE buffer at 4 °C for 2 h with rotation. Samples were cleared by ultracentrifugation with a TLA 100.3 rotor (Beckman Optima TL) at 4 °C for 30 min, and the supernatant was taken for nuclear extract. Protein concentration was quantified using a modified Bradford assay (Bio-Rad). 1 mg nuclear extract was adjusted to 300 µl total volume with NE buffer to perform immunoprecipiation (IP) in duplicate. Protein G Dynabeads or streptavidin M-280 Dynabeads (Life Technologies) were washed three times in PBS with 0.1% Tween-20 and 0.1% BSA. Nuclear extracts were cleared for 30 min at 4 °C with 25 µl protein G Dynabeads. For streptavidin pulldown, 50 µl of streptavidin M-280 Dynabeads were added to the nuclear extract and incubated at 4 °C for 2 h with rotation. To test whether the Tavi tag was required for streptavidin pulldown, nuclear extracts were split and incubated with or without 200 U TEV protease (Invitrogen) in the absence of a reducing agent and without agitation at 4 °C for ≥ 4 h before IP. For antibody IP, 5 µg of antibody was added to the nuclear extract and incubated overnight at 4 °C with rotation. Protein G beads were blocked in wash buffer overnight at 4 °C with rotation. Blocked beads were then incubated with antibody-bound nuclear extract for 2 h at 4 °C with rotation. Beads were washed four times in PBS with 0.1% Tween-20 and split into two equal volumes. Each sample was resuspended in 25 µl loading buffer with 50 mM DTT and boiled for 10 min at 95 °C before loading on a 4-12% Bis-Tris NuPage gel (Life Technologies).
Chromatin immunoprecipitation. Forebrain tissues from male mice at 20 weeks of age were homogenized in cross-linking buffer (1% formaldehyde (wt/vol), 10 mM HEPES (pH 7.5), 100 mM NaCl, 1 mM EDTA, 1 mM EGTA) and cross-linked for 5 min at room temperature (RT). After quenching with 125 mM glycine, cross-linked tissue was washed with ice-cold PBS and dounced with 16 strokes in lysis buffer (50 mM HEPES (pH 7.5), 140 mM NaCl, 1 mM EDTA, 1 mM EGTA, 10% glycerol (vol/vol), 0.5% NP-40 (vol/vol), and 0.25% Triton X-100 (vol/vol) with protease inhibitors). Nuclei were pelleted, washed and resuspended in chromatin buffer (10 mM Tris-HCl (pH 8.0), 1 mM EDTA, and 0.5 mM EGTA with protease inhibitors). Chromatin was sonicated using a Diagenode Bioruptor, and salt and detergent were added to adjust the chromatin buffer to 0.5% Triton X-100, 150 mM NaCl, 10 mM EDTA, and 0.1% sodium deoxycholate (DOC, vol/vol), and precleared at 4 °C with protein A Dynabeads (Invitrogen). For immunoprecipitation, 3 µg purified rabbit anti-MeCP2 IgG (in house) or nonspecific rabbit IgG control (Millipore NI01) was incubated with 45 µg chromatin for 4 h, followed by an overnight incubation with pre-blocked protein A Dynabeads, at 4 °C with rotation. Bead-bound chromatin was washed with low-salt buffer (50 mM HEPES, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% DOC), high-salt buffer (50 mM HEPES, pH 7.5, 500 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% DOC), LiCl buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA, 0.5% NP-40, 0.5% DOC) and TE buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA). Chromatin was eluted with elution buffer (50 mM Tris-HCl, pH 8.0, 10 mM EDTA, and 1% SDS (wt/vol)), digested with proteinase K (0.5 mg ml −1 ), and reversed cross-linked at 65 °C overnight. After RNase A treatment, DNA fragments were extracted with phenolchloroform and ethanol-precipitated.
qRT-PCR analysis was carried out using SYBR green detection (Life Technologies) on an ABI Prism 7900HT Real-Time PCR System (Applied Biosystems). The percentage input for each amplicon was determined by comparing the average threshold cycle of the immunoprecipitated DNA to a standard curve generated using serial dilutions of the input DNA and interpolating the 'fraction of input' value for this sample.
Subnuclear fractionation. To prepare nucleoplasm-enriched proteins, cortices were dounce homogenized in 5 ml NE10 buffer (20 mM HEPES, pH 7.5, 10 mM KCl, 1 mM MgCl 2 , 0.1% Triton X-100, and 15 mM β-mercaptoethanol) 30 times using a loose pestle. The resulting nuclei were washed with NE10 buffer and rotated in NE300 buffer (20 mM HEPES, pH 7.5, 300 mM NaCl, 10 mM KCl, 1 mM MgCl 2 , 0.1% Triton X-100, and 15 mM β-mercaptoethanol) for 1 h at 4 °C. Samples were centrifuged at 500 × g for 5 min, and the supernatant, which represents the nucleosolic fraction, was collected and saved. The insoluble pellet, consisting of the chromatin-bound fraction, was washed in NE150 buffer and incubated with 500 units of benzonase (Sigma-Aldrich) for 5 min at room temperature. The pellet was then resuspended in 50 µl NE150 buffer (20 mM HEPES, pH 7.5, 150 mM NaCl, 10 mM KCl, 1 mM MgCl 2 , 0.1% Triton X-100, and 15 mM β-mercaptoethanol) and rotated for 1 h at 4 °C. Samples were centrifuged at 16,000 × g, and the supernatant was collected as the chromatinbound fraction.
FACS isolation of neuronal nuclei for RT-PCR and RNA-seq. Nuclei were isolated from fresh cortical tissue for FACS under ice-cold and nuclease-free conditions. Mouse cortices were rapidly resected on ice and subjected to dounce homogenization in homogenization buffer (0.32 M sucrose, 5 mM CaCl 2 , 3 mM MgAc 2 , 10 mM Tris-HCl, pH 8.0, 0.1% Triton, 0.1 mM EDTA, Roche Complete Protease Inhibitor without EDTA). Homogenates were layered onto a sucrose cushion (1.8 M sucrose, 10 mM Tris-HCl, pH 8.0, 3 mM MgAc 2 Roche Complete Protease Inhibitor without EDTA) and centrifuged in a Beckman Coulter L7 Ultracentrifuge at 25,000 r.p.m. at 4 °C for 2.5 h using a Beckman Coulter SW28 swinging bucket rotor. Nuclei were resuspended and washed once in blocking buffer (1× PBS, 0.5% BSA (Sigma A4503), RNasin Plus RNase Inhibitor (Promega)) and pelleted using a tabletop centrifuge at 5,000 RCF at 4 °C for 10 min. Nuclei were resuspended in blocking buffer to a concentration of ~6 × 10 6 nuclei/ml, blocked for 20 min at 4 °C with rotation, then incubated with streptavidin Dylight 650 (1:1,000, Fisher 84547) and Alexa 488-conjugated anti-NeuN antibody (1:1,000, Millipore MAB377X) for 30 min at 4 °C with rotation. After a 5-min incubation with 1:1.000 DAPI to enable singlet detection during FACS, labeled nuclei were washed for an additional 30 min at 4 °C with blocking buffer, pelleted and resuspended in blocking buffer with 1% BSA. A BD Biosciences Influx cell sorter at the University of Pennsylvania Flow Cytometry and Cell Sorting Facility was used to identify cell-type-specific populations of nuclei, and 1.2-2.5 × 10 5 singlet nuclei from specified populations were directly sorted into Qiagen Buffer RLT Plus for immediate lysis and stabilization of RNA transcripts. Total nuclear RNA was processed using the Qiagen AllPrep DNA/RNA mini kit according to manufacturer instructions, with exception to the on-column DNaseI treatment. RNA was eluted from RNeasy mini spin columns and treated with DNaseI (Qiagen 79254) for 25 min at room temperature, then precipitated with glycogen and sodium acetate and stored in ethanol at −80 °C. Ethanol precipitation of nuclear RNA was carried out to completion before initiating RT-PCR or RNA-seq library construction.
For RNA-seq, total RNA was prepared from FACS-isolated cortical nuclei of male mice at 6 weeks (TAVI, T158M, R106W, 2-3 mice per biological replicate, 4 independently sorted biological replicates total) and female mice at 18 weeks (TAVI, T158M, R106W, 1 mouse per biological replicate, 2 independently sorted biological replicates total). No method of randomization was used to determine how animals were allocated to experimental groups, which was determined by genotype with matching age and sex. The numbers of biological replicates used for differential gene-expression analysis are in compliance with ENCODE consortium long RNA-seq recommendations (≥2 replicates). Furthermore, the total amount of RNA isolated from 120,000-250,000 sorted nuclei was used as input for library construction; hence differential gene-expression comparisons between FACS-isolated Mecp2 control and mutant neurons are performed using RNA from equivalent numbers of neuronal nuclei. Total RNA was depleted of ribosomal RNAs, subjected to 5 min of heat fragmentation, and converted to strand-specific cDNA libraries using the TruSeq Total RNA library prep kit with RiboZero depletion (Illumina). Multiplexed libraries were submitted for 100 paired-end sequencing on the Illumina HiSeq 2000/2500 platform at the University of Pennsylvania Next Generation Sequencing Core facility, yielding approximately 30-40 million total reads per library. 90-95% of total reads were uniquely mapped to the mouse Ensembl GRCm38/mm10 mouse genomic assembly.
RT-PCR.
For RT-PCR of FACS-isolated cortical nuclei, total RNA was prepared (as described above) from 120,000 sorted nuclei of TAVI or R106W male mice at 6 weeks of age (2-3 mice pooled per biological replicate, 3 independently sorted biological replicates total). For remaining RT-PCR assays, total RNA was isolated from whole tissue or unsorted cortical nuclei of WT, TAVI, T158M, or R106W mice as specified in figure legends (1 mouse per biological replicate, 3 biological replicates total). Total RNA was converted to cDNA with random hexamers using the SuperScript III First-Strand Synthesis System (Invitrogen). RT-PCR was performed on a ABI Prism 7900HT Real-Time PCR System (Applied Biosystems). To validate cell-type-specific cortical nuclei populations ( Fig. 2d  and Supplementary Fig. 3i,j) , exon-spanning Taqman gene-expression assays to detect mRNA transcripts for the following genes:
A geometric mean was calculated to normalize mRNA expression levels to multiple housekeeping genes (Actb, B2m, and Pgk1), and cell-type-enrichment for each sorted population was determined relative to the total mixed population of DAPI + nuclei. For RT-PCR validation of low expressing genes and subcellular gene-expression changes ( Fig. 4h and Supplementary Fig. 8) , primers against primary transcripts and mRNAs were used (Supplementary Table 2) , and geometric means were calculated to normalize mRNA expression levels to multiple housekeeping genes (Actb, B2m, and Pgk1).
GRO-seq.
Nuclei were isolated from fresh cortical tissue of TAVI or R106W male mice at 6 weeks of age (2 mice pooled per biological replicate, 2 biological replicates total) under ice-cold and nuclease-free conditions as described in the preceding section. After ultracentrifugation, nuclei were resuspended and washed once in PBS (1× PBS, RNasin Plus RNase Inhibitor (Promega)) and pelleted using a tabletop centrifuge at 5,000 RCF at 4 °C for 10 min. Nuclei were resuspended in PBS, pipetted through a 0.22-µm filter and counted using a hemocytometer. Nuclei were then pelleted, resuspended to a concentration of 5 × 10 6 -10 × 10 6 nuclei per 100 µl in glycerol storage buffer (50 mM Tris, pH 8.3, 40% glycerol, 5 mM MgCl 2 , 0.1 mM), and flash frozen in liquid N 2 for storage until needed.
For each nuclear run-on (NRO), 100 µl of nuclei was mixed with 46.5 µl NRO Reaction Buffer (10 mM Tris, pH 8.0, 5 mM MgCl 2 , 1 mM DTT, 300 mM KCl), 3.5 µl Nucleoside Mix (50 µM ATP, 50 µM GTP, 2 µM CTP, 50 µM Br-UTP, 0.4 U/µl RNasin), and 50 µl 2% Sarkosyl Nuclear Run On Stop Solution (20 mM Tris, pH 7.4, 10 mM EDTA, 2% SDS). The NRO reaction was performed at 30 °C for 5 min, then terminated by a 20-min incubation with DNAse I at 37 °C, followed by 1 h incubation with 225 µl NRO Stop Buffer (20 mM Tris, pH 7.4, 10 mM EDTA, 2% SDS) and proteinase K at 55 °C. Phenol-extracted RNA was fragmented with 0.2 N NaOH, and BrdU-RNA was isolated three consecutive times with BrdU-antibody beads, treated with enzymatic tobacco acid pyrophosphatase (TAP) and T4 polynucleotide kinase (PNK) to remove the cap and 3′ phosphate and to add a 5′ phosphate, as well as Illumina TruSeq small RNA sample prep kit adaptor ligations between BrU-RNA isolation steps as described 40, 58 .
RNA-seq mapping, read counting, and differential expression analysis. The mouse mm10 genomic sequence (Mus_musculus.GRCm38.75.dna.primary_ assembly.fa.gz) and gene information (Mus_musculus.GRCm38.75.gtf.gz) were downloaded from Ensembl release 75. The genome files used for mapping were built by STAR (version 2.3.0) 59 using the parameters 'STAR-runMode genom-eGenerate-runThreadN 12 -genomeDir ./-genomeFastaFiles Mus_musculus.GRCm38.75.dna.primary_ assembly.fa.gz-sjdbGTFfile Mus_musculus.GRCm38.75.gtf-sjdbOverhang 100' . The FASTQ files were mapped to the mouse Ensembl GRCm38/mm10 genome assembly by STAR (version 2.3.0) using the parameters '-genomeDir ENSEMBL_75_mm10-runThreadN 10-outFilterMultimapNmax 1-outFilter MismatchNmax 3' . Perl scripts generated in house were used to count the number of read pairs that mapped to genic regions (exon + intron) for each gene. If one end of a read pair overlapped with the annotated genomic region of a given gene and the other did not, the read pair was included in the final count for that gene. The total number of read pairs that overlapped within a given gene represented the final read count for that gene. All intron and exon-mapped reads were used for differentially expressed gene comparisons, which were performed by using the R packages edgeR (v3.10.0) 60 and DEseq2 (v1.8.0) 61 . Genes exhibiting low expression due to a substantially low number of mapped reads and whose edgeR CPM values satisfied the condition 'rowSums(cpm(data_y)) < 2' were filtered out from differential gene-expression analyses. Conversely, genes with 'rowSums(cpm(data_y)) ≥ 2' were retained for differential geneexpression analyses. FDR < 0.05 was set to identify differentially expressed genes, and no fold-change cutoff was applied. For each comparison, the results of both edgeR and DESeq2 analyses were merged into a final nonredundant and FDRcontrolled list of genes to avoid method-specific biases. The mean fold change and the mean FDR generated from both methods were used for generating plots and heatmaps.
RBP data pre-processing and analysis. To determine the enrichment of neuronally expressed RBPs on gene transcripts, raw HITS-CLIP reads derived from the mouse brain were obtained from publicly available data sets in the GEO repository (Supplementary Table 3 ). The quality of raw reads were assessed with FastQC and contaminants were removed using Trimgalore with parameters '-q 15-length 20-stringency 5' . Remaining reads were aligned to a mouse reference genome derived from the Ensembl v75 archived assembly using STAR (version 2.5) 59 with parameters '-outFilterMultimapNmax 1-outFilterScoreMinOver-Lread 0-outFilterMatchNminOverLread 0.5-alignEndsType Local' . Replicates were merged and then subsampled to match the sample with the lowest library size. Genome annotation from Ensembl v75 and in-house-developed scripts facilitated the calculation of RBP coverage in gene models. Genes not included in groups A-H (Fig. 4f) were filtered out. For k-means clustering of RBPs, raw read counts were first normalized using the variance stabilizing transformation function in DESeq2 (ref. 61) , and the R packages factoextra, cluster, and NbClust were used to perform a Silhouette coefficient analysis and cluster genes based on the optimal k number of clusters. The Kruskal-Wallis test, followed by a post hoc Wilcoxon rank sum test with Holm's correction for multiple comparisons, was used to identify statistically significant differences in RBP enrichment within each gene cluster. RBP gene clusters were then used to perform one-tailed Fisher's exact test with genes from groups A-H to identify RBP enrichments that significantly associated with genes displaying subcellular differences in geneexpression changes in R106W mice. Functional enrichment of differentially expressed genes. For DAVID gene ontology, a list of differentially expressed protein-coding genes was compared to a background list of actively expressed protein-coding genes from their respective cell type. Statistically significant terms (Benjamini P < 0.01, FDR < 0.05) were plotted for Supplementary Figure 3c,d . For GSEA, we performed a seeded, pre-ranked GSEA from lists of differentially expressed protein-coding genes (ranked by fold change) using the September 2015 Mouse GO Gene Set Release (http://download.baderlab.org/EM_Genesets/September_24_2015/ Mouse/). GSEA network associations (P < 0.1, Q < 0.1) were visualized using the Enrichment Map application (v2.0.1) in Cytoscape (v3.2.1) 62,63 and clustered using gene set overlap coefficients.
PCA. PCA was performed with the top 500 genes exhibiting the highest row variance using the plotPCA function in the R package DESeq2. Principal components were plotted using Graphpad Prism version 6.0 for Mac (GraphPad Software).
Determination of actively expressed genes. Actively expressed genes for excitatory and inhibitory neurons were determined by calculating the normalized FPKM (zFPKM) and using ZFPKM ≥ 3 for the active gene cutoff as previously described 64 .
Statistical analyses. Statistical analyses were performed using Graphpad Prism version 6.0 for Mac and R 65 . No statistical method was used to estimate sample size, as pre-specified effect sizes were not assumed. No animals or samples were excluded from analyses. Individual statistical tests are fully stated in the main text or figure legends. Comparisons of normally distributed data consisting of two groups with equal variances (F-test equality of variance P > 0.05) were analyzed using Student's t-test, and unequal variances (F-test equality of variance P < 0.05) using Students t-test with Welch's correction for unequal variance. Comparisons of normally distributed data consisting of three or more groups were analyzed using one-way ANOVA with the appropriate post hoc test. Comparison of two or more factors across multiple groups was analyzed using a two-way ANOVA with Sidak's correction for multiple comparisons. Comparisons of non-normally distributed data were analyzed using the Mann-Whitney/Wilcoxon test (two groups) or the Kruskal-Wallis test (three or more groups) with the appropriate post hoc test. For multiple comparisons, all P values are adjusted using the Holm-Bonferroni correction unless otherwise indicated. Experimental design and analytical details are also listed in the Life Sciences Reporting Summary.
Main figure statistical analyses. Figure 1e : n replicates = 3, one-way ANOVA (F = 25.55, P = 0.0012); Tukey's multiple comparisons correction applied. Figure 1f : left, n WT = 4, n TAVI = 5, n T158M = 4, n R106W = 4; one-way ANOVA (F = 12.4, P = 0.0004); Sidak's multiple comparisons correction applied. Right, n WT = 4, n TAVI = 5, n T158M = 4, n R106W = 4; one-way ANOVA (F = 0.2977, P = 0.8264); Sidak's multiple comparisons correction applied. Figure 1g : n WT = 20, n TAVI = 11, n KO = 6, n T158M = 6, n R106W = 12; one-way ANOVA (F = 20.05, P < 0.0001); Tukey's multiple comparison correction applied. Figure 1j : n WT = 31, n TAVI = 23, n KO = 17, n T158M = 39, n R106W = 26, Mantel-Cox (χ 2 = 109.3, df = 4, P < 0.0001). Figure 2d : n replicates = 3, two-way ANOVA, control (cell-type-gene interaction, F = 42.68, P < 0.0001; cell type, F = 222.0, P < 0.0001; gene, F = 80.03, P < 0.0001), non-neuronal (cell-type-gene interaction, F = 12.47, P < 0.0001; cell type, F = 109.8, P < 0.0001; gene, F = 7.655, P = 0.0027), EXC-specific (cell-type-gene interaction, F = 4.376, P = 0.0198; cell type, F = 1227, P < 0.0001; gene, F = 0.3267, P = 0.5756), INH-specific (cell-type-gene interaction, F = 3.047, P = 0.0040; cell type, F = 646.5, P < 0.001; gene, F = 2.916, P = 0.033); Dunnett's multiple comparisons correction applied. Figure 4e : Top, n = 10,390 genes, Kolmogorov-Smirnov P < 2.2e-16 for each nascent or nuclear RNA versus whole-cell RNA comparison, no correction for multiple comparisons. Figure 4f : n = 10, 390 genes, Kruskal-Wallis P Group A < 2.2 × 10 −16 (χ 2 = 2664.8, df = 2), P Group B < 2.2 × 10 −16 (χ 2 = 290.18, df = 2), P Group C < 2.2 × 10 −16 (χ 2 = 2403.3, df = 2), P Group D < 2.2 × 10 −16 (χ 2 = 319.36, df = 2), P Group E < 2.2 × 10 −16 (χ 2 = 1483.8, df = 2), P Group F < 2.2 × 10 −16 (χ 2 = 1385.8, df = 2), P Group G < 2.2 × 10 −16 (χ 2 = 2522.9, df = 2), P Group H < 2.2 × 10 −16 (χ 2 = 2442.7, df = 2); Pairwise Wilcoxon rank sum P displayed. Figure 4h : left, primary transcripts + mRNA RT-PCR (group trend), n Group A/C = 7 genes, n Group B = 5 genes, n Group D = 5 genes, two-way ANOVA, (subcellular compartment-gene group interaction, F = 5.699, P = 0.0084; subcellular compartment, F = 1.419, P = 0.2436; gene group, F = 16.14, P < 0.0001); Sidak's multiple comparisons correction applied. Right, primary transcripts only RT-PCR (group trend), n Group A/c = 7 genes, n Group B = 5 genes, n Group D = 5 genes, two-way ANOVA, (subcellular compartment-gene group interaction, F = 0.182, P = 0.8345; subcellular compartment, F = 0.1334, P = 0.7176; gene group, F = 15.12, P < 0.0001); Sidak's multiple comparisons correction applied. Figure 5a : two-way ANOVA (genotype-time interaction, F = 2.987, P = 0.0712; genotype, F = 41.14, P < 0.0001; time, F = 7.332, P = 0.0129; subjects (matching), F = 1.873, P = 0.0744). Figure 5b : FACS isolation of cortical mosaic excitatory neuronal nuclei from heterozygous TAVI, T158M, or R106W female mice. Figure 5c : n T158M = 4, n R106W = 9, Two-way ANOVA (population-genotype interaction, F = 0.3320, P = 0.5703; population, F = 111.1, P < 0.0001; genotype, F = 0.332, P = 0.5703). Figure 5d : n TAVI = 12, n T158M = 4, n R106W = 9, One-way ANOVA (F = 0.9376, P = 0.4067). n/a Confirmed The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
